Creatine supplement shows cognitive benefits: slows early Alzheimer's decline by 30% and improves mental performance, studies find
By
Daniel Okoro
11h ago· 8 min readenNews
100/100
Golden Brown
Bagelometer↗
Toasted golden, schmeared with insight. Top of the rack.
Score100TypenewsSentimentpositive
Summary
A comprehensive review (2025) and clinical trial (2026) reveal that creatine, widely used as a muscle-building supplement, also crosses the blood-brain barrier to boost brain energy levels. Key findings include: a 30% slowdown in cognitive decline for early Alzheimer's patients versus placebo, improved cognitive performance in sleep-deprived healthy adults after a single dose, and enhanced outcomes when added to cognitive behavioral therapy for depression patients. These cognitive benefits are not disclosed on supplement labels.
Key quotes
· 5 pulledTens of millions of people take creatine every day. They bought it for their muscles. Almost none of them know that the same supplement is crossing the blood-brain barrier, raising phosphocreatine levels in their neurons.
In early Alzheimer's patients, it slowed cognitive decline by approximately 30% versus placebo in a controlled trial.
In healthy adults under sleep deprivation, a single dose measurably improved cognitive performance.
In depression patients, adding it to cognitive behavioral therapy significantly improved outcomes beyond therapy alone.
None of this is mentioned on the label.
Tens of millions of people take creatine every day for their muscles. A comprehensive review and a landmark clinical trial published in 2025 and 2026 have now documented what the same supplement is quietly doing to their brains. Creatine crosses the blood
